Risk factors for invasive mold infection after COVID-19: case-control study
Esma Eryilmaz-Eren1, Hafize Sav2, Zuhal Ozer-Simsek3
1Kayseri City Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey.
Background:
Invasive mold infections (IMI) have become common in patients with severe COVID-19 pneumonia, which are difficult to diagnose and treat, with a high mortality rate.
Objective:
The aim of this study was to determine risk factors for invasive mold infections associated with COVID-19.
Methods:
In this prospective, case-control study, patients treated for severe COVID-19 pneumonia in intensive care units with invasive mold infection were compared with severe COVID-19 pneumonia patients with no secondary infection (bacterial or fungal). Demographics, treatments received and outcomes were compared.
Results:
Twenty patients were included in the IMI group and 19 patients in the control group. Invasive aspergillosis was observed in 13 patients (65.0%) while mucormycosis was observed in seven patients (35.0%). Demographics and clinical characteristics were similar between IMI and control group (p>0.005). The 28-day mortality was 60.0% in the IMI group and 15.8% in the control group (p=0.005). The use of steroids has been identified as the most important risk factor for developing IMI (90.0% vs. 15.8%, OR: 25.712, p=0.009).
Conclusion:
Rationale use of steroids, with appropriate indication, dose and duration is important in the treatment of severe COVID-19 pneumonia.
Insights
Invasive mold infections (IMI) are a serious risk for severe COVID-19 patients. Steroid use is the primary risk factor, highlighting the need for careful management in these critically ill individuals.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Invasive mold infections (IMI) pose a significant threat to patients with severe COVID-19 pneumonia.
- These infections are challenging to diagnose and treat, contributing to high mortality rates.
Purpose of the Study:
- To identify key risk factors associated with the development of invasive mold infections in patients with severe COVID-19 pneumonia.
Main Methods:
- A prospective case-control study compared patients with severe COVID-19 pneumonia and IMI to those without secondary infections.
- Demographics, treatments, and outcomes were analyzed between the groups.
Main Results:
- The study included 20 patients with IMI and 19 controls. Invasive aspergillosis and mucormycosis were the predominant fungal infections.
- Patients with IMI had a significantly higher 28-day mortality rate (60.0% vs. 15.8%).
- Steroid use emerged as the most significant risk factor for IMI (90.0% vs. 15.8%, OR: 25.712).
Conclusions:
- Judicious use of steroids, considering indication, dosage, and duration, is crucial for managing severe COVID-19 pneumonia.
- Minimizing steroid exposure may help reduce the incidence of invasive mold infections in this vulnerable patient population.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Asthma-I: Introduction


